Sanofi SA (SNY) Stock Price Today
Aura AI Summary
Key Stats
- $103.29BMARKET_CAP
- -VOLUME
- HealthSECTOR
- $52.34FIFTY_TWO_WEEK_HIGH
- $41.33FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- $119.78BENTERPRISE_VALUE
- 5.63%DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track Sanofi SA (SNY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Sanofi SA has traded between a low of $41.33 and a high of $52.34, highlighting its annual price range. Buy and sell Sanofi SA shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Most Recent News
Global golf simulators market to reach $5.5B by 2035 with 8.6% CAGR, driven by tech advances and rising home use
The global golf simulators market, valued at $2.4 billion in 2025, is projected to grow to $5.5 billion by 2035 at an 8.6% CAGR. Growth is fueled by technological improvements, increased commercial and residential use, and rising demand for indoor go...

Capital Power signs 10+ year deal to supply 250 MW to Meta's Alberta data centre by 2028
Capital Power Corporation has entered a long-term energy supply agreement to provide 250 megawatts of power to Meta's new data centre in Sturgeon County, Alberta, expected to be operational in late 2028. This deal strengthens Capital Power's position...

Class action lawsuit filed over Megan Holdings' alleged misleading IPO disclosures causing investor losses.
A securities class action lawsuit has been filed against Megan Holdings Limited by investors who purchased shares during its September 2025 IPO or between September 2025 and May 2026. The lawsuit alleges the company made false and misleading statemen...
